Although DKK3 did not directly affect soluble Aβ uptake by microglia in vitro, we observed clear changes in microglial activation in both DKK3-deficient and SJ-300–treated AD mice (Figs. 5, 6, and 8). This evidence concerns the gene DKK3 and Alzheimer disease.